Capricor Therapeutics (CAPR) executive compensation, 2026 proxy

Linda Marbán, Ph.D., Chief Executive Officer, was paid $3.5M in 2025, up 129% from $1.5M the year before.

Filed
April 10, 2026
Annual meeting
June 4, 2026
Pay year
2025
Named executives
3
CEO total pay
$3.5M+129% vs prior year
CEO pay in equity
84%$2.9M in awards
CEO 2025 Salary
$300,000Annual base salary
CEO 2025 Bonus
$270,000Paid for 2025 services
CEO Stock Awards
$2,940,920Grant date fair value

How Ph.D. was paid

$3.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary9%Bonus8%Stock awards84%All other compensation0%

Named executive officers

ExecutiveTotal
Linda Marbán, Ph.D.Chief Executive Officer$3,521,565
Karen Krasney, J.D.Executive Vice President & General Counsel$1,269,558
Anthony Bergmann, M.B.A.Chief Financial Officer$1,670,792

What changed and why

  • $3.5MChief executive officer total compensation increased to $3,521,565 in 2025 compared to $1,539,862 in the prior year.
  • $300KBase salary for the chief executive officer was set at $300,000 for fiscal 2025.
  • $270KBonus awarded to the chief executive officer for 2025 services was $270,000.
  • $2.9MStock awards granted to the chief executive officer totaled $2,940,920 in 2025.
  • Severance protection for named executive officers was increased to twelve months of salary in March 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.